Medtech investors and start-ups along with some of the world’s top corporates will gather in Dublin this week at The Medtech Strategist Innovation Summit 2017.

Over 40 medtech start-ups will pitch for funding from venture capital firms with over €26 billion in funds under management.
 
Irish medtech companies who will pitch to VCs during the conference include Mainstay Medical which is developing an implant to treat people with chronic lower back pain, Ponce De Leon Pharmaceuticals which is developing a product formulation aimed at postponing the onset of human frailty and the extension of human lifespan and Galway-based Loci Orthopaedics, that has developed a novel orthopaedic implant for the treatment of thumb base arthritis, a condition which affects over 5% of the population.
 
A number of the world’s top corporates will also attend including Johnson & Johnson, Medtronic and Baxter, as well as both global and local VCs such as Fountain Healthcare Partners, Lightstone Ventures and Sofinnova Partners
 
Supported by EY, Seroba Life Sciences, Enterprise Ireland and ICON among others, the event will take place from 25-27th April and will bring together venture capital firms seeking new opportunities to invest in the burgeoning medtech sector with emerging start-ups seeking investment and partnership.
 
Speaking ahead of the conference, Partner and Head of Life Sciences at EY, Aidan Meagher said, "This year’s conference will see even more medtech business leaders and innovators gather in Dublin than ever before, demonstrating that Ireland is punching well above its weight on the global medtech stage."

He added, "This is thanks to investment in key locations for innovation such as Galway which has established itself as the fourth largest incubation hub in the world for the medical devices sector – something which is no mean feat for a small country and further highlights Ireland’s position as a hub for medtech globally."

Source: www.businessworld.ie